Effects of Ezetimibe on Endothelial Progenitor Cells and Microparticles in High-Risk Patients

Cell Biochemistry and Biophysics

Volumn 70, Issue 1, 2014, Pages 687-696

  Lins, Lívia Campos Amaral ^a   França, Carolina Nunes ^a   Fonseca, Francisco Antonio Helfenstein ^a   Barbosa, Simone Pinto Melo ^a   Matos, Lívia Nascimento ^a   Aguirre, Ana Carolina ^a   Bianco, Henrique Tria ^a   do Amaral, Jonatas Bussador ^a   Izar, Maria Cristina ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

C reactive protein; Endothelial progenitors cells; Ezetimibe; Inflammation; Microparticles; Statins

Indexed keywords

ATORVASTATIN; AZETIDINE DERIVATIVE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; EZETIMIBE; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLE DERIVATIVE;

AGED; BLOOD; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOLOGY; DRUG EFFECTS; DRUG INTERACTION; ENDOTHELIAL PROGENITOR CELL; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK; THROMBOCYTE;

AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; BIOLOGICAL MARKERS; BLOOD PLATELETS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL-DERIVED MICROPARTICLES; CHOLESTEROL, LDL; DRUG INTERACTIONS; ENDOTHELIAL PROGENITOR CELLS; HEPTANOIC ACIDS; HUMANS; MIDDLE AGED; PYRROLES; RISK;

EID: 84906238185     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9973-9     Document Type: Article

References (34)

1. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine, 359, 2195-2207.
2. Chan, K. Y., Boucher, E. S., Gandhi, P. J., & Silva, M. A. (2004). HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. American Journal of Health-System Pharmacy, 61, 1676-1681.
3. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., et al. (2009). Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. The Lancet, 373, 1175-1182.
4. Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P., & Braunwald, E. (2005). Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: An analysis of the PROVE-IT TIMI-22 trial. Journal of the American College of Cardiology, 45, 1644-1648.
5. Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., et al. (2008). Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine, 359, 1343-1356.
6. Kastelein, J. J., Akdim, F., Stroes, E. S., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F., et al. (2008). Simvastatin with or without ezetimibe in familial hypercholesterolemia. New England Journal of Medicine, 358, 1431-1443.
7. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., et al. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. New England Journal of Medicine, 353, 999-1007.
8. Schmidt-Lucke, C., Rössig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kämper, U., et al. (2005). Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation, 111, 2981-2987.
9. +/Annexin V + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 112-116.
10. Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J. M., et al. (2000). Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation, 101, 841-843.
11. Resch, T., Pircher, A., Kähler, C. M., Pratschke, J., & Hilbe, W. (2012). Endothelial progenitor cells: Current issues on characterization and challenging clinical applications. Stem Cell Reviews and Reports, 8, 926-939.
12. Verma, S., Kuliszewski, M. A., Li, S. H., Szmitko, P. E., Zucco, L., Wang, C. H., et al. (2004). C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: Further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation, 109, 2058-2067.
13. Chen, J., Jin, J., Song, M., Dong, H., Zhao, G., & Huang, L. (2012). C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products. Gene, 496, 128-135.
14. Landmesser, U., Bahlmann, F., Mueller, M., Spiekermann, S., Kirchhoff, N., Schulz, S., et al. (2005). Simvastatin versus ezetimibe: Pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation, 111, 2356-2363.
15. Piorkowski, M., Fischer, S., Stellbaum, C., Jaster, M., Martus, P., Morguet, A. J., et al. (2007). Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: Is sufficient cholesterol-lowering enough to inhibit platelets? Journal of the American College of Cardiology, 49, 1035-1042.
16. Liu, P. Y., Liu, Y. W., Lin, L. J., Chen, J. H., & Liao, J. K. (2009). Evidence for statin pleiotropy in humans: Differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation, 119, 131-138.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
18. Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
19. França, C. N., Pinheiro, L. F., Izar, M. C., Brunialti, M. K., Salomão, R., Bianco, H. T., et al. (2012). Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circulation Journal, 76, 729-736.
20. da Silva, E. F., Fonseca, F. A., França, C. N., Ferreira, P. R., Izar, M. C., Salomão, R., et al. (2011). Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy. AIDS, 25, 1595-1601.
21. Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., et al. (1998). Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation, 98, 839-844.
22. Sattar, N., Murray, H. M., McConnachie, A., Blauw, G. J., Bollen, E. L., Buckley, B. M., et al. (2007). C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation, 115, 981-989.
23. Davis, H. R., & Veltri, E. P. (2007). Zetia: Inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Journal of Atherosclerosis and Thrombosis, 14, 99-108.
24. Zhou, Q., & Liao, J. K. (2010). Pleiotropic effects of statins. Basic research and clinical perspectives. Circulation Journal, 74, 818-826.
25. Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A. M., et al. (2001). Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 103, 2885-2890.
26. Pinheiro, L. F., França, C. N., Izar, M. C., Barbosa, S. P., Bianco, H. T., Kasmas, S. H., et al. (2012). Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease. International Journal of Cardiology, 158, 125-129.
27. Hristov, M., Fach, C., Becker, C., Heussen, N., Liehn, E. A., Blindt, R., et al. (2007). Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis, 192, 413-420.
28. Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent, C., Blackwell, L., Emberson, J., et al. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170, 000 participants in 26 randomized trials. The Lancet, 376, 1670-1681.
29. Kasmas, S. H., Izar, M. C., França, C. N., Ramos, S. C., Moreira, F. T., Helfenstein, T., et al. (2012). Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies. Brazilian Journal of Medical and Biological Research, 45, 1095-1101.
30. Barbosa, S. P., Lins, L. C., Fonseca, F. A., Matos, L. N., Aguirre, A. C., Bianco, H. T., et al. (2013). Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein. Life Sciences, 92, 845-851.
31. Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., et al. (2001). HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. Journal of Clinical Investigation, 108, 391-397.
32. Dimmeler, S., & Zeiher, A. M. (2004). Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis? Journal of Molecular Medicine, 82, 671-677.
33. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., et al. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research, 89, E1-E7.
34. Sari, I., Bozkaya, G., Kirbiyik, H., Alacacioglu, A., Ates, H., Sop, G., et al. (2012). Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis. Journal of Rheumatology, 39, 594-599.